Openings: The Pearl launches a second location at Boston Landing (67 Guest St.), serving seafood and raw bar delights from owners Mika and Malik Winder. They opened their first location to acclaim ...

At the beginning of the year Incyte paid $750m to Morphosys for the CD-19 targeting antibody, which has been approved in combination with BMS’ Revlimid (lenalidomide) for adults with relapsed or ...

BOSTON -- The Boston University Terriers are Beanpot champs for the 32nd time in school history after beating rival Boston College, 4-1, in the title bout at TD Garden on Monday night. The ...

Incyte has agreed a deal with Germany’s MorphoSys to license an antibody that could be an alternative to therapies for blood cancers sold by Amgen, Novartis and Gilead Sciences. Incyte is paying ...